UT Arlington Professor Awarded $1.9 Million to Study Clostridium Difficile Treatment

July 29, 2011

"julian Hurdle UT Arlington Professor"

Julian Hurdle awarded $1.9 million to study hospital infection. Photo credit: UT Arlington News Center

According to a news release from The University of Texas (UT) at Arlington News Center, a UT Arlington microbiologist has been awarded $1.9 million in funding from the National Institutes of Health, National Center for Complementary and Alternative Medicine.

The funding is to support the research of Julian Hurdle, an assistant professor of biology, in his quest to determine “the effect of reutericyclin compounds on the bacteria Clostridium difficile or C. difficile.

Richard Lee, a medicinal chemist and faculty member of St. Jude Children’s Research Hospital in Memphis, Tennessee, will serve as co-investigator.

“Developing treatments to combat serious public health threats such as hospital infections is the type of research work that occurs at national research universities like UT Arlington,” said Ron Elsenbaumer, UT Arlington Vice President for Research. “Dr. Hurdle’s work could be the first step toward a valuable new therapy that will help save lives.”

According to the news release, reutericyclin is an antimicrobial coumpound.  It is naturally produced by a probiotic organism known as Lactobacillus reuteri.  In their previous research, Hurdle and Lee have been successful in producing synthetic forms of reutericyclin with improved antibacterial properties.

Leave a Comment

Previous post:

Next post: